Valsartan 5/160 mg Tablet
Amlodipine Besylate · Valsartan
Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
MFDS item code 201308535 · Approved 2013.07.30
This product's status changed to Expired on 2023.07.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
This medication is used for the treatment of essential hypertension that is uncontrolled by monotherapy with amlodipine or valsartan. Essential hypertension is a condition characterized by abnormally high blood pressure, and this medication effectively lowers blood pressure to reduce the risk of cardiovascular diseases, thereby assisting in the improvement of the patient's health status.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used by individuals with allergies to this medicine or similar medications, pregnant or nursing women, or patients with severe kidney or liver dysfunction. Patients who are sodium or fluid depleted, have hyperkalemia, renal artery stenosis, have recently undergone kidney transplantation, have a history of angioedema, or suffer from heart failure or have had a myocardial infarction, should use this medication with special caution. Side effects may include dizziness, headache, swelling, low blood pressure, palpitations, cough, dyspepsia, skin rash, and others; consult a doctor immediately if any atypical symptoms occur. Caution is advised while driving or operating machinery as dizziness or fatigue may occur. This medication may interact with other antihypertensive medications, potassium supplements, diuretics, certain antibiotics, grapefruit juice, etc., so inform your doctor about any other medications you are taking. Women who are pregnant or planning to become pregnant should not use this medication, and nursing women are also advised to avoid it. Safety and effectiveness in children under 18 years of age have not been sufficiently established, so its use in this age group is not recommended. In cases of overdose, there is a risk of severe hypotension or tachycardia; therefore, it is crucial to adhere to the prescribed dosage, and if an overdose is suspected, seek immediate medical attention.
Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, decreased sensation, dysgeusia, peripheral neuropathy, excessive muscle tone, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperature between 1 to 30 degrees Celsius at room temperature.
Dark yellow oval film-coated tablet
28 tablets (14 tablets/Alu-Alu X2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate · Valsartan
Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.